Cipla To Slash Rates Of Six Anti-Cancer Medications
Sat, 05/12/2012 - 07:41 | 
Notwithstanding the debate surrounding the fall in rates of anti-cancer medications, Indian pharma major Cipla is eyeing to slash rates of at least six more products-much in lines of cutting of anti-AIDS medications a decade ago-to make them reasonable for patients.
Shares of Arena Pharmaceuticals Inc. nearly doubled in cost in premarket trading on May 11, the day after FDA consultants recommended nod for its potential weight-loss medication, lorcaserin.
Taro Pharmacetical Industries Ltd. declared that the Special group of its Board of Directors set up to assess the offer from Sun Pharmaceutical Industries Ltd.
Tags: Orchid Pharma Bags USFDA Authorization For Olanzapine Tabs ANDA
The Chennai-based global pharma major Orchid Chemicals& Pharmaceuticals Ltd. declared obtaining the nod from the USFDA for its ANDA for Olanzapine pills in the potencies comprising 2.5mg, 5mg, 7.5mg, 10mg, 15mg and 20 mg.
Natco Pharma Limited has been chosen as the National Award victor of the 'Golden Peacock Award for Corporate Social Responsibility' for the year 2012.
US drug manufacturer Jazz Pharmaceuticals stated that it has inked a definitive deal to get hold of privately-held, UK-headquartered EUSA Pharma for $650 million in cash and a potential $50 million landmark.
Piramal Healthcare Eyes More Buyouts In Pharma, Finance, Security Systems
After its second acquirement of molecular imaging development group of Germany's Bayer Pharma, Piramal Healthcare is looking at additional buyouts in pharmaceutical, home finance as well as home security systems businesses.
Vanda Pharmaceuticals Inc. stated that it has got hold of an exclusive international license from Eli Lilly and Co. in order to build up and market a small molecule neurokinin 1 receptor, or NK-1R, antagonist for all human indications.
Sun Pharmaceutical Industries has declared that USFDA has granted its arm an approval for its ANDA for generic edition of Seroquel, quetiapine fumarate tabs, in various potencies.
FDA Panel Backs Astellas Pharma's Overactive Bladder Medication
Tokyo-based Astellas Pharma has announced that its proposed medicine for addressing overactive bladder - Mirabegron, bagged the support of an FDA advisory board.
China’s pharmaceutical industry has registered a 21.4% y-o-y increase in output value for the initial two months to 234.27 billion yuan, with the growth rate down 7.1 percentage points as against the last year.
Scrip of Spectrum Pharmaceuticals declined on Thursday after the drug maker stated that a potential cancer cure missed its main objective in late-stage test.
Obamacare Should Be Encouraging For Healthcare Division
When President Barack Obama entered into the Patient Protection and Affordable Care Act (PPACA), commonly known as "Obamacare," during March 2010, it received large amounts of extolment and unfavorable judgment. The majority of individuals seem to feel sturdily in one direction or the other.
Scrip of drug manufacturer Aurobindo Pharma saw huge selling pressure after the firm’s MD was named in a chargesheet lodged by the Central Bureau of Investigation (CBI).
Gerresheimer AG, a German supplier of pharma and healthcare products has got hold of 70% equity stake in the Indian bottles manufacturer Neutral Glass & Allied Industries Pvt Ltd for an unrevealed sum.
Arena Pharma Declines As Analyst Salshes Rating
Shares of Arena Pharmaceuticals declined Wednesday after a Piper Jaffray forecaster demoted the stock, mentioning that the share cost has developed as Wall Street turns more promising that Arena's obesity medication lorcaserin will get sanctioned.
Dr Reddy’s Laboratories, Sun Pharma and Lupin Ltd have received a final nod for their Quetiapine Fumaratac tabs of 25 mg, 50 mg, 100 mg, 200 mg, 300 mg and 400 mg intensities from USFDA.
Maker of generic pharmaceuticals and active pharma components Aurobindo Pharma Ltd. declared that the company had received final authorizations from the USFDA to sell Quetiapine Fumarate tabs 25mg, 50mg, 100mg, 150mg, 200mg, 300mg and 400mg.
Teva To Trasfer Listing To NYSE By May 2012; Watson Near To $7 billion Actavis Drug Agreement
Teva Pharmaceutical Industries Ltd stated that it is moving its listing of U.S. traded shares to NYSE from the Nasdaq Global Select Market by May 2012.
A federal advisory board on March 20 disapproved the experimental medicine, ridaforolimus, produced by Ariad Pharmaceuticals (ARIA) and joined hands with Merck & Co. (MRK), for utilization in patients with soft-tissue or bone sarcomas.
GlaxoSmithKline and Johnson & Johnson have joined hands with venture capital company Index Ventures to introduce a fund to make investment in life sciences firms, continuing Big Pharma's push to tap into novel drugs while bringing down the billions it has historically expended on internal research and growth.
Watson Pharma Seeks FDA Nod For Cholesterol Drug Niaspan
Generic drug maker Watson Pharmaceuticals Inc. stated that it is seeking favorable reception from the Food and Drug Administration to sell a generic edition of Abbott Laboratories' cholesterol medication Niaspan.
Stock market analyst Siddharth Bhamre, Angel Broking, has maintained buy rating on Aurobindo Pharma stock with a target of Rs 132.
Mankind Pharma, a large pharmaceutical firm, is making entry in the eye care and skin treatment group and proposes to introduce two novel products in the market shortly.
Natco Pharma Bags Obligatory Licence; Pharma Sector Calls Budget A Complete Disappointment
The verdict to permit Natco Pharma to market Bayer's patented cancer medication Nexavar has divided the pharmaceutical business with domestic companies welcoming it whereas MNCs stated 'arbitrarily' utilization of compulsory licenses will destabilize novelty in the division.
As usual, the pharmaceutical sector has called the Union Budget a complete disappointment. Though Pranab Mukherjee has given a big bonanza to the pharma division via extension of the 200% weighted subtraction for R&D spending, raise in service tax to 12% has come as a blow to the division.
Shasun Pharmaceuticals has completed the sale of Velachery possessions for around Rs 29 crore and also announced interim dividend of Rs 2 a share, the reports said.
Novartis Pharma Rolls Out Two Drugs In Ghana
Novartis Pharma, a pharmaceutical firm based in Switzerland, has launched Galvus-Galvusmet, a novel medication for the cure of diabetes, and Exforge HCT for the treatment of high blood pressure onto the Ghanaian market.
Elder Pharmaceuticals stock declined on Wednesday after the media quoted that Income Tax division has raided premises of top company’s functionaries.
The federal administration said that it is working with pharma firms to address deficits in the supply of some prescription medications, comprising a request that they look for alternative sources of the medicines outside Canada.
Industry Minister Mohamad Suleman Hidayat said that capitalists from India are keen in making novel investments in Indonesia, mainly in the pharmaceutical and health equipment segments.
